- Home
- ACIU vs PESI Comparison
ACIU vs PESI Comparison
Compare ACIU & PESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- PESI
- Stock Information
- Founded
- ACIU 2003
- PESI 1990
- Country
- ACIU Switzerland
- PESI United States
- Employees
- ACIU N/A
- PESI N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- PESI Environmental Services
- Sector
- ACIU Health Care
- PESI Industrials
- Exchange
- ACIU Nasdaq
- PESI Nasdaq
- Market Cap
- ACIU 173.7M
- PESI 153.1M
- IPO Year
- ACIU 2016
- PESI 1992
- Fundamental
- Price
- ACIU $1.69
- PESI $9.52
- Analyst Decision
- ACIU Strong Buy
- PESI Strong Buy
- Analyst Count
- ACIU 2
- PESI 1
- Target Price
- ACIU $10.00
- PESI $18.00
- AVG Volume (30 Days)
- ACIU 137.1K
- PESI 181.7K
- Earning Date
- ACIU 04-30-2025
- PESI 05-08-2025
- Dividend Yield
- ACIU N/A
- PESI N/A
- EPS Growth
- ACIU N/A
- PESI N/A
- EPS
- ACIU N/A
- PESI N/A
- Revenue
- ACIU $32,014,254.00
- PESI $59,419,000.00
- Revenue This Year
- ACIU N/A
- PESI $38.20
- Revenue Next Year
- ACIU $676.94
- PESI $98.88
- P/E Ratio
- ACIU N/A
- PESI N/A
- Revenue Growth
- ACIU 91.20
- PESI N/A
- 52 Week Low
- ACIU $1.43
- PESI $6.25
- 52 Week High
- ACIU $4.98
- PESI $16.25
- Technical
- Relative Strength Index (RSI)
- ACIU 46.75
- PESI 71.32
- Support Level
- ACIU $1.55
- PESI $8.28
- Resistance Level
- ACIU $1.79
- PESI $9.76
- Average True Range (ATR)
- ACIU 0.10
- PESI 0.56
- MACD
- ACIU 0.03
- PESI 0.13
- Stochastic Oscillator
- ACIU 66.67
- PESI 86.81
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About PESI Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.